Fact CheckerSign in

NCT07629479Recruiting

Ejaculation-Preserving Versus Standard Bipolar TUEP for BPH

Bipolar Transurethral Enucleation of the Prostate With Preservation of Ejaculation in Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 5 Jun 2026

Brief summary (registry, in English)

This prospective randomized controlled trial will compare ejaculation-preserving bipolar transurethral enucleation of the prostate with standard bipolar transurethral enucleation of the prostate in sexually active men with benign prostatic hyperplasia and lower urinary tract symptoms after failed medical treatment. Participants will be randomly assigned to either ejaculation-preserving B-TUEP or standard B-TUEP. The study will evaluate preservation of ejaculatory function, erectile function, urinary symptom improvement, uroflowmetry outcomes, post-void residual urine, perioperative complications, and need for retreatment during follow-up.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
1 Jun 2026
Start date
8 Sept 2025
Primary completion date
Aug 2026
Lead sponsor
Beni-Suef University
NCT number
NCT07629479

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 8 Sept 2025 to the primary completion date, Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis or suspicion of prostate cancer.
  • Neurological disorders affecting lower urinary tract or sexual function.

Other

  • Preoperative sexual dysfunction.
  • Preoperative ejaculatory dysfunction.
  • Detrusor hypocontractility.
  • Catheter-dependent patients.
  • Patients with bladder stones.
  • Inability or refusal to provide informed consent.

Who the study is looking for

  • Male patients with lower urinary tract symptoms secondary to benign prostatic obstruction after failed medical treatment for at least 3 months.
  • Sexually active patients with a continuous relationship with the same partner.
  • International Prostate Symptom Score of 8 or greater.
  • Transrectal ultrasound-estimated prostate size between 40 and 100 cc.
  • Eligible for bipolar transurethral enucleation of the prostate.
  • Ability to complete the required sexual and urinary function questionnaires.
  • Ability to provide written informed consent.

Age in the registry: 50 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Urology- Beni-Suef University Hospitals
Coordinator of this site? Confirm its status
Banī SuwayfEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.